Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: Results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry

Circulation

Volumn 129, Issue 20, 2014, Pages 2005-2012

  Steinberg, Benjamin A ^a,b   Kim, Sunghee ^b   Thomas, Laine ^b   Fonarow, Gregg C ^c   Hylek, Elaine ^d   Ansell, Jack ^e   Go, Alan S ^f   Chang, Paul ^g   Kowey, Peter ^h   Gersh, Bernard J ⁱ   Mahaffey, Kenneth W ^j   Singer, Daniel E ^k   Piccini, Jonathan P ^a,b   Peterson, Eric D ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f KAISER PERMANENTE   (United States)

^g JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^h LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

ⁱ MAYO CLINIC   (United States)

^j STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

atrial fibrillation; hemorrhage; risk assessment; stroke

Indexed keywords

ADULT; AGED; ANEMIA; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE REGISTRY; EMPIRICAL RISK ASSESSMENT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PATIENT ASSESSMENT; PHYSICIAN ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; TRANSIENT ISCHEMIC ATTACK;

ATRIAL FIBRILLATION; HEMORRHAGE; RISK ASSESSMENT; STROKE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HEMORRHAGE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84901045089     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.008643     Document Type: Article

References (15)

1. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006;9:348-356. (Pubitemid 44337788)
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991;22:983-988
3. Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA. 1999;281:1830-1835. (Pubitemid 29231134)
4. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-2870
5. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011;58:395-401
6. Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33:1500-1510
7. Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: The AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. J Am Coll Cardiol. 2012;60:861-867
8. Sandhu RK, Bakal JA, Ezekowitz JA, McAlister FA. Risk stratification schemes, anticoagulation use and outcomes: The risk-Treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation. Heart. 2011;97:2046-2050
9. Piccini JP, Fraulo ES, Ansell JE, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Kong MH, Lopes RD, Mills RM, Peterson ED. Outcomes registry for better informed treatment of atrial fibrillation: Rationale and design of ORBIT-AF. Am Heart J. 2011;162:606-612.e1
10. Keogh C, Wallace E, Dillon C, Dimitrov BD, Fahey T. Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke. A systematic review and meta-analysis. Thromb Haemost. 2011;106:528-538
11. Altman DG. Practical Statistics for Medical Research. London, United Kingdom: Chapman and Hall; 1991
12. Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportions. 3rd ed. New York, New York John Wiley & Sons; 2003
13. Eisenberg MS, Cummins RO. Defibrillation performed by the emergency medical technician. Circulation. 1986;74(6 pt 2):IV9-I12
14. Brand DA, Newcomer LN, Freiburger A, Tian H. Cardiologists' practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction. J Am Coll Cardiol. 1995;26:1432-1436
15. Hayward RA, Asch SM, Hogan MM, Hofer TP, Kerr EA. Sins of omission: Getting too little medical care may be the greatest threat to patient safety. J Gen Intern Med. 2005;20:686-691. (Pubitemid 41140998)